What Should You Know About Kisunla, The Newly FDA-Approved Alzheimer’s Drug
The Food and Drug Administration approved a new medication on July 2, 2024, for Alzheimer’s treatment [1]. The drug, Kisunla, is the third in a new class of treatments to slow disease progression. It bears similarities to Leqembi, a medication that was authorized for use in early-stage Alzheimer’s patients last year [2]. Another drug in … Continue reading "What Should You Know About Kisunla, The Newly FDA-Approved Alzheimer’s Drug"